Abel Hall, LLC PACB — PACIFIC BIOSCIENCES CALIF IN

Ownership history in Abel Hall, LLC  ·  5 quarters on record

AI Ownership Summary

Abel Hall, LLC reported PACIFIC BIOSCIENCES CALIF IN (PACB) in 5 quarterly 13F filings from 2025 Q2 through 2026 Q2. Peak portfolio weight reached 0.01% in 2025 Q4. The latest visible filing shows PACB at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this PACB ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Abel Hall, LLC's position in PACIFIC BIOSCIENCES CALIF IN, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

PACB was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.01% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q2 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

PACB stock page Abel Hall, LLC fund profile Abel Hall, LLC full holdings
How Abel Hall, LLC held PACB — position size vs. price
% of Fund (quarterly)    PACB price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 5 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 REDUCED — — — 14,963 -7,736 -34.1% 0.00% $25K 2026-07-24 $1.36
2026 Q1 ADDED — — — 22,699 +6,208 +37.6% 0.01% $30K 2026-04-28 $1.58
2025 Q4 ADDED — — — 16,491 +5,403 +48.7% 0.01% $31K 2026-02-17 $1.58
2025 Q3 REDUCED 7.5% +33.6% ❌ 11,088 -895 -7.5% 0.01% $14K 2025-11-17 $1.57
2025 Q2 INITIATED — — — 11,983 — — 0.01% $15K 2025-07-23 $1.69

🏢 Other funds also holding PACB

As of 2026 Q2 — sorted by position size

Koa Wealth Management, LLC 0.14% Mirador Capital Partners LP 3Y 7Y 0.07% KAVAR CAPITAL PARTNERS GROUP, LLC 3Y 0.02% NJ State Employees Deferred Compensation Plan 3Y 7Y 0.01% AdvisorNet Financial, Inc 3Y 7Y 0.01% Abacus Planning Group, Inc. 3Y 7Y 0.01% Wealth Architects, LLC 3Y 7Y 0.01% FNY Investment Advisers, LLC 3Y 7Y 0.01% China Universal Asset Management Co., Ltd. 3Y 0.0% Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 3Y 7Y 0.0%

FAQ About Abel Hall, LLC and PACB

These are the practical questions this page is built to answer before you even open the full history table.

How long has Abel Hall, LLC reported owning PACB?

Abel Hall, LLC reported PACB across 5 quarterly 13F filings, from 2025 Q2 through 2026 Q2.

What was the largest reported PACB position in Abel Hall, LLC's portfolio?

The largest reported portfolio weight for PACB was 0.01% in 2025 Q4.

What is the latest reported PACB position on this page?

The most recent filing on this page is 2026 Q2, when Abel Hall, LLC reported 14,963 shares, equal to 0.00% of portfolio, with an estimated market value of $25K.

What does the chart on this PACB ownership page compare?

The chart compares Abel Hall, LLC's quarterly PACB portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Abel Hall, LLC time their PACB position?

Based on 13F filing dates vs. subsequent PACB price moves, Abel Hall, LLC correctly timed 0 out of 4 reported position changes (0%). The annualised alpha on PACB relative to SPY over the holding period was -31.7%.

← Back to Abel Hall, LLC Holdings